Travere Therapeutics, Inc. (TVTX): SCHEDULE 13G filed Aug 7, 2026

Form type

SCHEDULE 13G

Filing date

Aug 7, 2026

Accession number

0000093751-26-000546

Filer

Travere Therapeutics, Inc. (CIK 1438533)